Omeprazol Pensa (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Pensa, is a proton pump inhibitor presented as an oral formulation for oral use. It reduces gastric acid secretion and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazol Pensa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor used to reduce gastric acid production in several acid‑related disorders. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Peptic ulcer disease: accelerates ulcer healing and helps prevent recurrence. - NSAID‑induced ulcer prophylaxis: lowers the risk of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication (in combination therapy): enhances bacterial eradication when combined with appropriate antibiotics.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Abdominal pain: discomfort in the upper abdomen. - Diarrhea: loose stools occurring intermittently. - Nausea: feeling of queasiness. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile infection: severe colitis associated with antibiotic‑like effects. - Hypomagnesemia: low serum magnesium levels with prolonged use. - Elevated liver enzymes: potential hepatic involvement. - Stevens‑Johnson syndrome: rare severe skin reaction. - Interstitial nephritis: inflammation of kidney interstitium.

Before initiating therapy, consider the following safety measures. - Renal function assessment: evaluate kidney status, especially in patients with chronic renal disease. - Magnesium monitoring: check serum magnesium during long‑term treatment. - Hepatic impairment: use with caution in patients with liver disease. - Known hypersensitivity: avoid if the patient has a documented allergy to omeprazole or related compounds. - Elderly patients: start at the lowest effective dose and monitor for adverse effects. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Ketoconazole: reduced absorption due to increased gastric pH. - Atazanavir: decreased plasma concentrations, compromising antiviral efficacy. - Nelfinavir: impaired absorption leading to sub‑therapeutic levels. - Clopidogrel: diminished activation, potentially reducing antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring more frequent monitoring. - Digoxin: may raise serum digoxin concentrations. - Methotrexate: reduced clearance, especially at high doses. - HIV protease inhibitors (e.g., ritonavir): may require dose adjustment. - Iron salts: decreased iron absorption, consider spacing administration.